Recombinant Human IL-9 Protein Summary
Product Specifications
Gln19-Ile144
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
209-ILB
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
209-ILB/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 100 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Scientific Data
Recombinant Human IL-9 (Catalog # 209-ILB) induces MO7e human megakaryocytic leukemic cell proliferation. The ED50 for this effect is 0.03-0.3 ng/mL.
Reconstitution Calculator
Background: IL-9
Interleukin-9 (IL-9), also known as P40 and MEA (mast cell growth-enhancing activity), is a 30-40 kDa glycosylated member of a cytokine family that includes Interleukins-2, -4, -7, -15, and -21. These proteins utilize heteromeric receptors containing the Common gamma chain ( gamma c) in addition to ligand-specific subunits. IL-9 interacts selectively with IL-9 R which then associates with gamma c to form the functional receptor complex. IL-9 contributes to allergic inflammation, autoimmunity-induced inflammation, parasite clearance from the GI tract, and Treg-mediated immune suppression (1, 2). It enhances the expansion and recruitment of mast cells and eosinophils as well as the production of IgE and Th2 cytokines (3‑6). It is required for anaphylactic responses to ingested allergens but not to systemic allergens (7). IL-9 plays multiple roles in the development and function of subsets within the CD4+ T cell lineage (8). It is expressed by activated Th9, Th17, Treg, and Th2 cells (3, 9‑12). IL-9 acts as an autocrine growth and activation factor for Th17, Treg, and mast cells (3, 11, 13). It also can inhibit immune responses by enhancing the suppressive properties of Treg and by recruiting immune-suppressive mast cells to sites of inflammation (11, 12). Mature human IL-9 shares 57% amino acid sequence identity with mouse and rat IL-9 (14, 15).
- Noelle, R.J. and E.C. Nowak (2010) Nat. Rev. Immunol. 10:683.
- Goswami, R. and M.H. Kaplan (2011) J. Immunol. 186:3283.
- Nowak, E.C. et al. (2009) J. Exp. Med. 206:1653.
- Townsend, M.J. et al. (2000) Immunity 13:573.
- Leech, M.D. and R.K. Grencis (2006) J. Immunol. 176:2505.
- Fawaz, L.M. et al. (2007) J. Allergy Clin. Immunol. 120:1208.
- Osterfeld, H. et al. (2010) J. Allergy Clin. Immunol. 125:469.
- Jabeen, R. and M.H. Kaplan (2012) Curr. Opin. Immunol. 24:303.
- Tan, C. et al. (2010) J. Immunol. 185:6795.
- Jager, A. et al. (2009) J. Immunol. 183:7169.
- Elyaman, W. et al. (2009) Proc. Natl. Acad. Sci. USA 106:12885.
- Lu, L.-F. et al. (2006) Nature 442:997.
- Stassen, M. et al. (2000) J. Immunol. 164:5549.
- Yang, Y.-C. et al. (1989) Blood 74:1880.
- Renauld, J.-C. et al. (1990) Cytokine 2:9.
Citations for Recombinant Human IL-9 Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
10
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Cytokine responsive networks in human colonic epithelial organoids unveil a molecular classification of inflammatory bowel disease
Authors: P Pavlidis, A Tsakmaki, A Treveil, K Li, D Cozzetto, F Yang, U Niazi, BH Hayee, M Saqi, J Friedman, T Korcsmaros, G Bewick, N Powell
Cell Reports, 2022-09-27;40(13):111439.
Species: Human
Sample Types: Organoid
Applications: Bioassay -
Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease
Authors: Z Peng, S Jiang, M Wu, X Zhou, Q Wang
Mol. Vis., 2017-07-31;23(0):538-547.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Ref-1/APE1 as Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia
Authors: J Ding, ML Fishel, AM Reed, E McAdams, M Czader, AA Cardoso, MR Kelley
Mol. Cancer Ther., 2017-04-26;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis.
Authors: Liu J, Harberts E, Tammaro A, Girardi N, Filler R, Fishelevich R, Temann A, Licona-Limon P, Girardi M, Flavell R, Gaspari A
J Invest Dermatol, 2014-01-31;134(7):1903-11.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Pentraxin 3 (PTX3) expression in allergic asthmatic airways: role in airway smooth muscle migration and chemokine production.
Authors: Zhang J, Shan L, Koussih L, Redhu NS, Halayko AJ, Chakir J, Gounni AS
PLoS ONE, 2012-04-18;7(4):e34965.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
Authors: Nielsen N, Odum N, Urso B, Lanier LL, Spee P
PLoS ONE, 2012-02-22;7(2):e31959.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.
Authors: Qiu L, Lai R, Lin Q, Lau E, Thomazy DM, Calame D, Ford RJ, Kwak LW, Kirken RA, Amin HM
Blood, 2006-06-08;108(7):2407-15.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Protection of human conjunctival fibroblasts from NO-induced apoptosis by interleukin-4 or interleukin-13.
Authors: Fujitsu Y, Fukuda K, Kimura K, Seki K, Kumagai N, Nishida T
Invest. Ophthalmol. Vis. Sci., 2005-03-01;46(3):797-802.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways.
Authors: Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, Harper RW, Wu R
J. Immunol., 2004-09-01;173(5):3482-91.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia.
Authors: Vermeer PD, Harson R, Einwalter LA, Moninger T
Am. J. Respir. Cell Mol. Biol., 2003-03-01;28(3):286-95.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human IL-9 Protein
There are currently no reviews for this product. Be the first to review Recombinant Human IL-9 Protein and earn rewards!
Have you used Recombinant Human IL-9 Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image